Celularity Inc. Repayments of Related Party Debt
Celularity Inc. (CELU) reported Repayments of Related Party Debt of $5.90 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfRelatedPartyDebt · last filed 2026-04-30
- Celularity Inc. repayments of related party debt for the quarter ending 2025-12-31 was $0.00.
- Celularity Inc. repayments of related party debt for the quarter ending 2021-12-31 was $0.00.
- Celularity Inc. repayments of related party debt for the quarter ending 2019-12-31 was $0.00.
- Celularity Inc. repayments of related party debt for the quarter ending 2019-09-30 was $0.00.
- Celularity Inc. repayments of related party debt for fiscal 2025 was $5.90M.
- Celularity Inc. repayments of related party debt for fiscal 2021 was $5.00M.
- Celularity Inc. repayments of related party debt for fiscal 2019 was $280.00K.
| Period end | Repayments of Related Party Debt 3 month | Repayments of Related Party Debt 6 month | Repayments of Related Party Debt 9 month | Repayments of Related Party Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-30 | $5.90M 10-K · filed 2026-04-30 | ||
| 2025-09-30 | $5.90M 10-Q · filed 2025-11-14 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $5.00M 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $5.00M 10-Q · filed 2022-11-10 | |||
| 2019-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-24 | $0.00 derived: sum of 2 quarters · filed 2021-05-24 | $280.00K 10-K/A · filed 2021-05-24 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $280.00K 10-Q · filed 2020-11-16 | ||
| 2019-06-30 | $280.00K 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |